Development and validation of a multidisciplinary risk assessment scale for immune checkpoint inhibitor-associated myocarditis
ObjectiveTo develop a risk assessment scale for immune checkpoint inhibitor (ICI)-associated myocarditis based on multidisciplinary collaboration, and to evaluate its diagnostic performance. MethodsBased on multidisciplinary cooperation, integrating clinical experience from oncology and cardiology,...
Saved in:
| Main Authors: | Yanan DAI, Yuan LIU, Yuchen XU, Qingqing CAI, Yan WANG, Yuhong ZHOU, Leilei CHENG, Junbo GE |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shanghai Chinese Clinical Medicine Press Co., Ltd.
2025-08-01
|
| Series: | Zhongguo Linchuang Yixue |
| Subjects: | |
| Online Access: | https://www.c-jcm.com/article/doi/10.12025/j.issn.1008-6358.2025.20250469 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A review of immune checkpoint inhibitor-associated myocarditis: Epidemiology, pathogenesis, and biomarkers
by: Le Xu, et al.
Published: (2025-12-01) -
Immune checkpoint inhibitor-related myocarditis during DUO-E regimen for endometrial cancer: The first case report in gynecologic oncology
by: Eri Yamabe, et al.
Published: (2025-10-01) -
Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors
by: Abdulrahman Alghabban, MD, et al.
Published: (2025-05-01) -
Cardiotoxicity mechanisms of antitumor therapy with immune checkpoint inhibitors: new achievements
by: L. D. Khidirova, et al.
Published: (2024-06-01) -
Application of Immune Checkpoint Inhibitors in Cancer
by: Zhijun Chen, et al.
Published: (2025-08-01)